Immune system modulation via stimulation of phagocytosis by polysaccharides from Gracilaria algae

The entry "Immune system modulation via stimulation of phagocytosis by polysaccharides from Gracilaria algae" does **not** refer to a single well-defined molecular target such as a receptor, enzyme, or transporter. Instead, it describes an **immunomodulatory process** whereby bioactive polysaccharides extracted from red seaweeds of the genus *Gracilaria* enhance macrophage phagocytic activity. This effect is mediated through interaction with cell surface receptors such as dectin-1 and subsequent upregulation of cytoskeletal regulatory proteins like RAC1 and WASP in macrophages[1]. The result is enhanced cytoskeletal rearrangement and increased capacity for pathogen clearance. While these findings highlight important biological activities relevant to infection resistance and potential therapeutic applications as immune enhancers—particularly in aquaculture—the described entity is **not itself a canonical therapeutic target** but rather an immunological outcome induced by complex natural products[1]. Thus, it should not be classified alongside standard drug targets. If you require structured information about specific receptors involved (e.g., dectin-1), those should be listed separately using their proper names ("Dectin-1 receptor") with appropriate details.

Other names

Gracilaria polysaccharide-induced immune modulationSeaweed polysaccharide-mediated phagocytosis enhancementGracilaria-derived bioactive polysaccharides (context-dependent)